MLchartDataset catalogue

gliclazide

Term · Oncology and biomedicine · MLC-T-ONC-013956

A short-acting, relatively high-potency, second-generation sulfonylurea compound with hypoglycemic activity. Gliclazide also increases peripheral insulin sensitivity. This agent is metabolized by CYP2C9.

Table 1. Record
IdentifierMLC-T-ONC-013956
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-013956",
  "term": "gliclazide",
  "field": "Oncology and biomedicine",
  "definition": "A short-acting, relatively high-potency, second-generation sulfonylurea compound with hypoglycemic activity. Gliclazide also increases peripheral insulin sensitivity. This agent is metabolized by CYP2C9.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/gliclazide/"
}

Record 8,014 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.